Iain Shaw - Quotient Sciences

Iain Shaw

Senior Director, 14C Enabled Drug Development


Iain Shaw is Senior Director of 14C Enabled Drug Development at Quotient Sciences. Iain has over 30 years of experience in the pharmaceutical industry, including more than 20 years of drug development experience. Iain initially joined Pharmaceutical Profiles, which later became Quotient Sciences, as Director of Customer Service in 2008.

Prior to joining Quotient Sciences, Iain held early development program management, clinical development, and analytical positions at pharmaceutical companies and contract research organizations (CROs) including Covance (now Lab Corp Drug Development) and PPL Therapeutics.

Iain holds a Bachelor of Science in Agricultural Chemistry from the University of Glasgow.

Topics of interest
Quotient Sciences Logo
Iain Shaw, Human ADME, Clinical Pharmacology

A Decade of Human ADME at Quotient Sciences: Reviewing Key Study Design Variables and Outcomes

14 December 2022 Read More

Latest news from Quotient Sciences

More News
News & Announcements, Dr. Vanessa Zann, artificial intelligence Outsourcing Pharma interview with Dr. Vanessa Zann By: Dr. Vanessa Zann
Read More
News & Announcements, Interviews, Thierry Van Nieuwenhove, artificial intelligence Executive interview at DCAT with Life Sciences Knowledge Hub featuring Thierry Van Nieuwenhove
Read More
Get in touch
Humanity can't afford to wait, so neither can we.